Sign up to save your podcasts
Or
Share Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)
Marissa McPhillips met Michelle, in her capacity as CEO of Alltrna, for a constructive conversation around the critical role industry plays in developing innovative treatments for rare disease. We heard how it takes an environment that supports innovation, with incentives, novel clinical trial designs, and other enabling regulations – with Michelle urging the rare disease community to continue to push for these things.
For more information about Alltrna and how they are scaling rare disease drug development by pioneering tRNA medicines to treat Stop Codon Disease, check out their LinkedIn page, YouTube channel, and X account (formerly Twitter).
View all episodes
By Axiom Healthcare StrategiesMarissa McPhillips met Michelle, in her capacity as CEO of Alltrna, for a constructive conversation around the critical role industry plays in developing innovative treatments for rare disease. We heard how it takes an environment that supports innovation, with incentives, novel clinical trial designs, and other enabling regulations – with Michelle urging the rare disease community to continue to push for these things.
For more information about Alltrna and how they are scaling rare disease drug development by pioneering tRNA medicines to treat Stop Codon Disease, check out their LinkedIn page, YouTube channel, and X account (formerly Twitter).